These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 24135073)

  • 1. NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same?
    Fornai M; Antonioli L; Colucci R; Pellegrini C; Giustarini G; Testai L; Martelli A; Matarangasi A; Natale G; Calderone V; Tuccori M; Scarpignato C; Blandizzi C
    J Pharmacol Exp Ther; 2014 Jan; 348(1):86-95. PubMed ID: 24135073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal effects of nonselective and selective cyclooxygenase inhibitors in the rat.
    Menozzi A; Pozzoli C; Giovannini E; Solenghi E; Grandi D; Bonardi S; Bertini S; Vasina V; Coruzzi G
    Eur J Pharmacol; 2006 Dec; 552(1-3):143-50. PubMed ID: 17069793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
    Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
    Zwolinska-Wcislo M; Krzysiek-Maczka G; Ptak-Belowska A; Karczewska E; Pajdo R; Sliwowski Z; Urbanczyk K; Drozdowicz D; Konturek SJ; Pawlik WW; Brzozowski T
    J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the intestinal toxicity of celecoxib, a selective COX-2 inhibitor, and indomethacin in the experimental rat.
    Tibble JA; Sigthorsson G; Foster R; Bjarnason I
    Scand J Gastroenterol; 2000 Aug; 35(8):802-7. PubMed ID: 10994617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study.
    Maiden L; Thjodleifsson B; Seigal A; Bjarnason II; Scott D; Birgisson S; Bjarnason I
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1040-5. PubMed ID: 17625980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage.
    Fornai M; Natale G; Colucci R; Tuccori M; Carazzina G; Antonioli L; Baldi S; Lubrano V; Abramo A; Blandizzi C; Del Tacca M
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):79-87. PubMed ID: 16080005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility.
    Satoh H; Amagase K; Takeuchi K
    J Pharmacol Exp Ther; 2012 Nov; 343(2):270-7. PubMed ID: 22854201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs.
    Takeuchi K; Yokota A; Tanaka A; Takahira Y
    Dig Dis Sci; 2006 Jul; 51(7):1250-9. PubMed ID: 16944022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage.
    Takeuchi K; Tanaka A; Kato S; Amagase K; Satoh H
    Clin Chim Acta; 2010 Apr; 411(7-8):459-66. PubMed ID: 20074562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
    Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing.
    Colucci R; Antonioli L; Bernardini N; Ippolito C; Segnani C; Awwad O; Tuccori M; Blandizzi C; Scarpignato C; Fornai M
    J Pharmacol Exp Ther; 2012 Jul; 342(1):140-9. PubMed ID: 22495067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of COX-2 in nonsteroidal anti-inflammatory drug enteropathy in rodents.
    Hotz-Behofsits C; Simpson RJ; Walley M; Bjarnason IT
    Scand J Gastroenterol; 2010 Aug; 45(7-8):822-7. PubMed ID: 20441531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of small bowel injury by switching from nonselective nonsteroidal anti-inflammatory drugs to celecoxib in rheumatoid arthritis patients: a pilot study.
    Inoue T; Iijima H; Arimitsu J; Hagihara K; Kawai S; Shiraishi E; Hiyama S; Mukai A; Shinzaki S; Nishida T; Ogata A; Tsujii M; Takehara T
    Digestion; 2014; 89(2):124-32. PubMed ID: 24526219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSAID-induced small intestinal damage--roles of various pathogenic factors.
    Takeuchi K; Satoh H
    Digestion; 2015; 91(3):218-32. PubMed ID: 25791157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Involvement of endogenous tachykinins in the development of jejunal mucosa injury induced by on-steroidal anti-inflammatory drugs].
    Sendur P; Ceranowicz P; Sendur R; Cieszkowski J; Warzecha Z; Dembiński A
    Przegl Lek; 2013; 70(2):48-52. PubMed ID: 23879003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage.
    Takeuchi K; Tanaka A; Ohno R; Yokota A
    J Physiol Pharmacol; 2003 Dec; 54 Suppl 4():165-82. PubMed ID: 15075458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic targeting or genetic deletion of mitochondrial cyclophilin D protects from NSAID-induced small intestinal ulceration in mice.
    LoGuidice A; Ramirez-Alcantara V; Proli A; Gavillet B; Boelsterli UA
    Toxicol Sci; 2010 Nov; 118(1):276-85. PubMed ID: 20668000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats.
    Satoh H; Amagase K; Takeuchi K
    J Pharmacol Exp Ther; 2014 Feb; 348(2):227-35. PubMed ID: 24254524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.